Study of Different Treatment on People with Intermediate and High Risk Myelodysplastic Syndrome (MDS)

What we are studying

The main goal of this study is to learn if MDS patients who have a matched donor and receive transplant do better than other MDS patients who don’t have a donor and only get drugs to treat their MDS (no transplant). Researchers want to know how well study participants are able to do their normal activities after treatment. Researchers will ask study participants survey questions (health evaluations) by phone after their transplant.

Who we are studying

  • Men and Women
  • Races:
    • White
    • African American
    • Asian
    • American Indian or Alaska Native
    • Native Hawaiian or Pacific Islander
    • Other
  • All Ethnicities
  • Ages 50 - 75

Eligibility Criteria

  • Study participants may have received prior treatment
  • Diagnosed with MDS

What is involved

  • Study treatment will include either transplant or drug therapy
  • Follow up phone calls for 3 years

Compensation

None

Contact Information

Study Coordinator
Scarlett Hutchens
Email
snhutche@wakehealth.edu
Phone
336-713-6915

Disclaimer: The information on this website is for general informational purposes only and SHOULD NOT be relied upon as a substitute for sound professional medical advice, evaluation or care from your physician or other qualified health care provider.